Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 16 - Number 4


Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin

, 16(4): 288 - 304

Zhipeng Zou, Juan Chen, Jun Yang and Xiaochun Bai


DOI: 10.2174/1568009616666151113120830



A New Therapeutic Era in GCB and ABC Diffuse Large B-cell Lymphom a Molecular Subtypes: A Cell of Origin-Driven Review

, 16(4): 305 - 322

Jose D. Sandoval-Sus, Julio Chavez and Samir Dalia


DOI: 10.2174/1568009615666151030102539




Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer

, 16(4): 346 - 356

Xue-Qing Hu, Yang Sun, Eric Lau, Ming Zhao and Shi-Bing Su


DOI: 10.2174/1568009616666151207105851



Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer

, 16(4): 357 - 372

Niladri Shekhar Dey, Biswajit Mukherjee, Ruma Maji and Bhabani Sankar Satapathy


DOI: 10.2174/1568009616666151106120606



Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines

, 16(4): 373 - 385

Alessio Papi, Marzia Govoni, Carmen Ciavarella, Enzo Spisni, Marina Orlandi and Fulvia Farabegoli


DOI: 10.2174/1568009615666150817120931




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Oct-2021-ban

Related Journals

Related eBooks

eBooks Catalog